enVVeno Medical (NASDAQ: NVNO) — Perfil da empresa, notícias e dados financeiros
enVVeno Medical develops pioneering devices for venous diseases, focusing on innovative and minimally invasive treatments.

enVVeno Medical
enVVeno Medical (NASDAQ:NVNO) specializes in pioneering medical devices designed to advance the treatment of venous diseases. A primary focus of enVVeno Medical is on developing innovative solutions that can significantly improve the quality of life for patients suffering from such conditions. Their projects are diverse, ranging from early-stage research to the commercialization of products aimed at addressing venous insufficiencies. Objectives for enVVeno Medical include pushing the boundaries of medical technology to provide effective, minimally invasive treatments, expanding their product portfolio to cover a wider range of venous disease treatments, and establishing strong market presence globally. Through cutting-edge research and development, enVVeno Medical is committed to advancing healthcare for those afflicted by venous diseases.
Resumo
Operações
Produtos e/ou serviços de enVVeno Medical
- Venous Disease Product Line: Innovative solutions targeting chronic venous insufficiency, improving patient outcomes.
- Medical Devices: Cutting-edge devices designed for the treatment of varicose veins, enhancing procedural efficiency and safety.
- Compression Therapy Solutions: Advanced compression therapy products to aid in the recovery and management of venous disorders.
- Diagnostic Tools: High-tech diagnostic equipment for accurate assessment of venous conditions, facilitating targeted treatments.
- Educational Programs: Comprehensive educational resources for healthcare professionals, focusing on the latest techniques in venous disease treatment.
equipe executiva do enVVeno Medical
- Robert A. BermanCEO & Director
- Jennifer BrightChief Financial Officer
- Hamed AlaviSenior VP & Chief Technology Officer
- Marc H. GlickmanSenior VP & Chief Medical Officer
- Sandy PriettoVice President of Marketing
- Avi SharmaSenior Vice President of Clinical, Regulatory & Quality
Últimas notícias sobre a enVVeno Medical
Principais indicadores financeiros
Resultados divulgados pela enVVeno Medical , em USD.
- Cap. de mercado
- 4,7 mi
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -25.0
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -20,9 mi | -19,5 mi | |
| 0 | -23,8 mi | -21,8 mi | |
| 0 | -25,2 mi | -23,5 mi | |
| 0 | -24,9 mi | -24,7 mi |